Lilly quietly completes purchase of Padcev competitor, estimated at half a B USD
30 Aug 2023 //
ENDPTS
Synaffix allies with Emergence in $360M biobuck ADC pact
07 Sep 2022 //
FIERCEBIOTECH
Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal
06 Sep 2022 //
PRNEWSWIRE
Emergence strengthens leadership team with the appointment of Hatem Azim as CMO
07 Jun 2022 //
GLOBENEWSWIRE
Emergence Therapeutics raises €87 million Series A financing toNectin-4 ADC
07 Dec 2021 //
GLOBENEWSWIRE
Emergence Therapeutics raises €87 mSeries A financing to advance Nectin-4 ADC
07 Dec 2021 //
GLOBENEWSWIRE
Emergence Therapeutics Closes €87 Million Series A Financing Round
07 Dec 2021 //
CONTRACTPHARMA